863 PRECLINICAL CHARACTERIZATION OF MIRAVIRSEN (MIR), AN OLIGONUCLEOTIDE TARGETING MIR-122 IN THE HCV GENOTYPE 1B REPLICON SYSTEM by Ottosen, S, Parsley, T, Zeh, K, Raney, A, Hodges, M, Patick, A.K

Get full text

1202 SEQUENCE ANALYSIS OF HCV VARIANTS FROM A PHASE IIA TRIAL OF MIRAVIRSEN (MIR), AN OLIGONUCLEOTIDE TARGETING MIR-122, IN TREATMENT NAIVE PATIENTS WITH CHRONIC HCV INFECTION by Patick, A.K, Chen, A, van Doorn, L.J, van der Veer, E, Zeh, K, Raney, A.K, Hodges, M.R

Get full text

Evaluation of the antiviral activity and cytotoxicity of nelfinavir in combination with reverse transcriptase and protease inhibitors in an in vitro acute HIV-1 infection model by Bloom, L.A., Boritzki, T.J., Patick, A.K.

Get full text

In vitro isolation and characterization of a human rhinovirus variant resistant to a 3C protease inhibitor by Binford, S., Ford, C., Fuhrman, S., Webber, S.E., Okano, K., Patick, A.K.

Get full text

Rhinovirus 3C protease inhibitors are efficacious against several related picornaviruses by Ford, C., Binford, S., Fuhrman, S., Webber, S.E., Okano, K., Patick, A.K.

Get full text

Evaluation of the antiviral activity and cytotoxicity of peptidic inhibitors of human rhinovirus 3C protease, a novel target for antiviral intervention by Patick, A.K., Ford, C., Binford, S., Fuhrman, S., Brothers, M., Meador, J., Webber, S.E., Okano, K., Zalman, L., Worland, S.

Get full text

Characterization of siamycin I, an HIV fusion inhibitor by Lin, P.-F., Samanta, H., Bechtold, C.M., Deminie, C., Alam, M., Riccardi, K., Rose, R.E., Patick, A.K., White, R., Colonno, R.J.

Get full text